AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
PHARMACOKINETICS OF ALPHA-IFN-2B IN CHRONIC HEPATITIS-C VIRUS PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS OR WITH NORMAL RENAL-FUNCTION - CLINICAL IMPLICATIONS
Authors: ROSTAING L CHATELUT E PAYEN JL IZOPET J THALAMAS C TONTHAT H PASCAL JP DURAND D CANAL P
Citation: L. Rostaing et al., PHARMACOKINETICS OF ALPHA-IFN-2B IN CHRONIC HEPATITIS-C VIRUS PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS OR WITH NORMAL RENAL-FUNCTION - CLINICAL IMPLICATIONS, Journal of the American Society of Nephrology, 9(12), 1998, pp. 2344-2348
CO-VARIABLES INFLUENCING 5-FLUOROURACIL CLEARANCE DURING CONTINUOUS VENOUS INFUSION - A NONMEM ANALYSIS
Authors: ETIENNE MC CHATELUT E PIVOT X LAVIT M PUJOL A CANAL P MILANO G
Citation: Mc. Etienne et al., CO-VARIABLES INFLUENCING 5-FLUOROURACIL CLEARANCE DURING CONTINUOUS VENOUS INFUSION - A NONMEM ANALYSIS, European journal of cancer, 34(1), 1998, pp. 92-97
PHARMACOKINETICS (PK) AND PHARMACODYNAMICS OF THE CARBOPLATIN (CBDCA)OXALIPLATIN (L-OHP) COMBINATION IN PATIENTS (PTS) WITH ADVANCED MALIGNANCIES - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I TRIAL/
Authors: BEKRADDA M CHATELUT E CVITKOVIC E SOULIE P CANAL P MISSET JL DUPONTANDRE G BENSMAINE MA BUGAT R
Citation: M. Bekradda et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS OF THE CARBOPLATIN (CBDCA)OXALIPLATIN (L-OHP) COMBINATION IN PATIENTS (PTS) WITH ADVANCED MALIGNANCIES - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I TRIAL/, Annals of oncology, 9, 1998, pp. 447-447
A LIMITED-SAMPLING METHOD FOR EVALUATION OF THE AREA-UNDER-THE-CURVE OF ULTRAFILTERABLE CARBOPLATIN IN CHILDREN
Authors: DOZ F URIEN S CHATELUT E MICHON J RUBIE H ZUCKER JM CANAL P BASTIAN G
Citation: F. Doz et al., A LIMITED-SAMPLING METHOD FOR EVALUATION OF THE AREA-UNDER-THE-CURVE OF ULTRAFILTERABLE CARBOPLATIN IN CHILDREN, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 250-254
COMPARISON OF THE PHARMACOKINETICS AND EFFICACY OF IRINOTECAN AFTER ADMINISTRATION BY THE INTRAVENOUS VERSUS INTRAPERITONEAL ROUTE IN MICE
Authors: GUICHARD S CHATELUT E LOCHON I BUGAT R MAHJOUBI M CANAL P
Citation: S. Guichard et al., COMPARISON OF THE PHARMACOKINETICS AND EFFICACY OF IRINOTECAN AFTER ADMINISTRATION BY THE INTRAVENOUS VERSUS INTRAPERITONEAL ROUTE IN MICE, Cancer chemotherapy and pharmacology, 42(2), 1998, pp. 165-170
POPULATION PHARMACOKINETICS OF TOTAL AND UNBOUND ETOPOSIDE
Authors: NGUYEN L CHATELUT E CHEVREAU C TRANCHAND B LOCHON I BACHAUD JM PUJOL A HOUIN G BUGAT R CANAL P
Citation: L. Nguyen et al., POPULATION PHARMACOKINETICS OF TOTAL AND UNBOUND ETOPOSIDE, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 125-132
MODIFICATION OF PACLITAXEL METABOLISM IN A CANCER-PATIENT BY INDUCTION OF CYTOCHROME-P450 3A4
Authors: MONSARRAT B CHATELUT E ROYER I ALVINERIE P DUBOIS J DEZEUSE A ROCHE H CROS S WRIGHT M CANAL P
Citation: B. Monsarrat et al., MODIFICATION OF PACLITAXEL METABOLISM IN A CANCER-PATIENT BY INDUCTION OF CYTOCHROME-P450 3A4, Drug metabolism and disposition, 26(3), 1998, pp. 229-233
VARIABILITY OF DIHYDROPYRIMIDINE DESHYDROGENASE (DPD) ACTIVITY IN NORMAL, INFLAMMATORY AND TUMORAL TISSUES OF COLON AND LIVER IN HUMANS
Authors: GUIMBAUD R GUICHARD S BERTRAND V APARICIO T TERRET C BUGAT R COUTURIER D CHATELUT E CANAL P CHAUSSADE S
Citation: R. Guimbaud et al., VARIABILITY OF DIHYDROPYRIMIDINE DESHYDROGENASE (DPD) ACTIVITY IN NORMAL, INFLAMMATORY AND TUMORAL TISSUES OF COLON AND LIVER IN HUMANS, Gastroenterology, 114(4), 1998, pp. 2483-2483
IMPROVEMENT OF THE COCKCROFT-GAULT EQUATION FOR PREDICTING GLOMERULAR-FILTRATION IN CANCER-PATIENTS
Authors: MARTIN L CHATELUT E BONEU A ROSTAING L ROUSSILHES C CASELLES O CANAL P
Citation: L. Martin et al., IMPROVEMENT OF THE COCKCROFT-GAULT EQUATION FOR PREDICTING GLOMERULAR-FILTRATION IN CANCER-PATIENTS, Bulletin du cancer, 85(7), 1998, pp. 631-636
PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS - RESPONSE
Authors: CHATELUT E CHEVREAU C CANAL P
Citation: E. Chatelut et al., PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS - RESPONSE, Journal of the National Cancer Institute, 89(3), 1997, pp. 261-262
IS CHATELUT FORMULA APPLICABLE IN OBESE PATIENTS FOR PREDICTING CARBOPLATIN CLEARANCE
Authors: BENEZET S CHATELUT E GUIMBAUD R CHEVREAU C BUGAT R CANAL P
Citation: S. Benezet et al., IS CHATELUT FORMULA APPLICABLE IN OBESE PATIENTS FOR PREDICTING CARBOPLATIN CLEARANCE, European journal of cancer, 33, 1997, pp. 1123-1123
HOW TO PREDICT CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL CHARACTERISTICS IN OBESE PATIENTS
Authors: BENEZET S GUIMBAUD R CHATELUT E CHEVREAU C BUGAT R CANAL P
Citation: S. Benezet et al., HOW TO PREDICT CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL CHARACTERISTICS IN OBESE PATIENTS, Annals of oncology, 8(6), 1997, pp. 607-609
RADIOTHERAPY WITH CONCOMITANT CONTINUOUS CISPLATIN INFUSION FOR UNRESECTABLE TUMORS OF THE UPPER AERODIGESTIVE TRACT - RESULTS OF A PHASE-ISTUDY
Authors: BACHAUD JM CHATELUT E CANAL P ALBIN N YARDENI E DAVID JM SERRANO E DALYSCHVEITZER N
Citation: Jm. Bachaud et al., RADIOTHERAPY WITH CONCOMITANT CONTINUOUS CISPLATIN INFUSION FOR UNRESECTABLE TUMORS OF THE UPPER AERODIGESTIVE TRACT - RESULTS OF A PHASE-ISTUDY, American journal of clinical oncology, 20(1), 1997, pp. 1-5
INEFFICACY OF EXCHANGE-TRANSFUSION IN A METHOTREXATE INTOXICATION
Authors: BENEZET S CHATELUT E BAGHERI H RIGALHUGUET F NGUYEN L POURRAT J ROBERT A MONTASTRUC JL CANAL P
Citation: S. Benezet et al., INEFFICACY OF EXCHANGE-TRANSFUSION IN A METHOTREXATE INTOXICATION, Bulletin du cancer, 84(8), 1997, pp. 788-790
BAYESIAN-ESTIMATION OF ETOPOSIDE PHARMACO KINETIC PARAMETERS
Authors: EVENE E CHATELUT E TRANCHAND B CANAL P LOCHON I ILIADIS A ARDIET CJ
Citation: E. Evene et al., BAYESIAN-ESTIMATION OF ETOPOSIDE PHARMACO KINETIC PARAMETERS, Bulletin du cancer, 84(7), 1997, pp. 699-703
IN-VITRO AND IN-VIVO PROTEIN-BINDING OF METHOTREXATE ASSESSED BY MICRODIALYSIS
Authors: MAIA MBD SAIVIN S CHATELUT E MALMARY MF HOUIN G
Citation: Mbd. Maia et al., IN-VITRO AND IN-VIVO PROTEIN-BINDING OF METHOTREXATE ASSESSED BY MICRODIALYSIS, International journal of clinical pharmacology and therapeutics, 34(8), 1996, pp. 335-341
POPULATION PHARMACOKINETICS OF CARBOPLATIN IN CHILDREN
Authors: CHATELUT E BODDY AV PENG B RUBIE H LAVIT M DEZEUZE A PEARSON ADJ ROCHE H ROBERT A NEWELL DR CANAL P
Citation: E. Chatelut et al., POPULATION PHARMACOKINETICS OF CARBOPLATIN IN CHILDREN, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 436-443
DOSE OPTIMIZATION IN CLINICAL ONCOLOGY - PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS
Authors: CANAL P CHATELUT E
Citation: P. Canal et E. Chatelut, DOSE OPTIMIZATION IN CLINICAL ONCOLOGY - PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS, Bulletin du cancer, 83(4), 1996, pp. 256-265
CHILD CEREBROSPINAL-FLUID ANALYSIS BY CAPILLARY ELECTROPHORESIS AND LASER-INDUCED FLUORESCENCE DETECTION
Authors: NOUADJE G RUBIE H CHATELUT E CANAL P NERTZ M PUIG P COUDERC F
Citation: G. Nouadje et al., CHILD CEREBROSPINAL-FLUID ANALYSIS BY CAPILLARY ELECTROPHORESIS AND LASER-INDUCED FLUORESCENCE DETECTION, Journal of chromatography, 717(1-2), 1995, pp. 293-298
PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS
Authors: CHATELUT E CANAL P BRUNNER V CHEVREAU C PUJOL A BONEU A ROCHE H HOUIN G BUGAT R
Citation: E. Chatelut et al., PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS, Journal of the National Cancer Institute, 87(8), 1995, pp. 573-580
COMPARISON OF METHODS FOR THE ESTIMATION OF CARBOPLATIN PHARMACOKINETICS IN PEDIATRIC CANCER-PATIENTS
Authors: PENG B BODDY AV COLE M PEARSON ADJ CHATELUT E RUBIE H NEWELL DR
Citation: B. Peng et al., COMPARISON OF METHODS FOR THE ESTIMATION OF CARBOPLATIN PHARMACOKINETICS IN PEDIATRIC CANCER-PATIENTS, European journal of cancer, 31A(11), 1995, pp. 1804-1810
PHARMACOKINETICS OF IRINOTECAN AND ITS METABOLITES IN HUMAN BLOOD, BILE, AND URINE
Authors: LOKIEC F CANAL P GAY C CHATELUT E ARMAND JP ROCHE H BUGAT R GONCALVES E MATHIEUBOUE A
Citation: F. Lokiec et al., PHARMACOKINETICS OF IRINOTECAN AND ITS METABOLITES IN HUMAN BLOOD, BILE, AND URINE, Cancer chemotherapy and pharmacology, 36(1), 1995, pp. 79-82
A PHARMACOLOGICALLY GUIDED PHASE-I STUDY OF CARBOPLATIN COMBINATION WITH METHOTREXATE AND VINBLASTINE IN ADVANCED UROTHELIAL CANCER
Authors: CHATELUT E CHEVREAU C BRUNNER V MARTINEZ M HOUIN G BUGAT R CANAL P
Citation: E. Chatelut et al., A PHARMACOLOGICALLY GUIDED PHASE-I STUDY OF CARBOPLATIN COMBINATION WITH METHOTREXATE AND VINBLASTINE IN ADVANCED UROTHELIAL CANCER, Cancer chemotherapy and pharmacology, 35(5), 1995, pp. 391-396
CEREBROSPINAL-FLUID CONCENTRATIONS OF CARBOPLATIN IN A PATIENT WITHOUT BLOOD-BRAIN-BARRIER DISRUPTION
Authors: BRUNNER V HOUYAU P CHATELUT E ROCHE H CANAL P
Citation: V. Brunner et al., CEREBROSPINAL-FLUID CONCENTRATIONS OF CARBOPLATIN IN A PATIENT WITHOUT BLOOD-BRAIN-BARRIER DISRUPTION, Cancer chemotherapy and pharmacology, 35(4), 1995, pp. 352-353
RELATIONSHIPS BETWEEN HEMATOLOGICAL TOXIC ITY AND TOTAL AND FREE ETOPOSIDE PLASMATIC LEVELS WITH DAILY ORAL ETOPOSIDE ADMINISTRATION
Authors: LAVIT M CHEVREAU C CHATELUT E DEFENIN V LOCHON I HOUIN G BUGAT R CANAL P
Citation: M. Lavit et al., RELATIONSHIPS BETWEEN HEMATOLOGICAL TOXIC ITY AND TOTAL AND FREE ETOPOSIDE PLASMATIC LEVELS WITH DAILY ORAL ETOPOSIDE ADMINISTRATION, Bulletin du cancer, 82(8), 1995, pp. 660-664
Risultati: 1-25 | 26-37